SPCX has spent the past week locked in a standoff — analysts raising targets, shorts holding record positions, and the stock sliding further from both.
The short base is the defining feature of this setup. Shares short hit 167.8 million on July 14, barely changed from July 13's 166.6 million — a pause, not a retreat. The sevenfold expansion that took place between July 8 and July 10 (from 23.3 million to 161 million shares) has now consolidated into a stable record position. Bears are not adding aggressively, but none are covering either. Availability has recovered slightly to 32% from the all-time low of 24.8% set on July 13 — tight enough to remain firmly in constrained territory, but less acute than 48 hours ago. Cost to borrow has climbed to 2.14%, up 48% on the week, though well below the mid-June spike above 13%. The ORTEX short score has jumped to 67.6 from 50.4 ten days ago, reflecting how quickly the short thesis was established and how firmly it has since anchored.
Options positioning has turned more defensive this week. The put/call ratio hit 1.08 on July 14 — the highest reading since the stock began trading and up sharply from the 0.82–0.91 range that prevailed through most of June and early July. That shift aligns with the stock's 9% weekly loss and 15% monthly decline to $136.08. The two signals are telling the same story: real-money participants are increasingly positioned for further downside, even as borrow availability has stabilised at the margin.
The Street, meanwhile, has moved in the opposite direction. Needham raised its target to $250 on July 15. Evercore ISI initiated Outperform at $230 on July 14. Those actions follow a cluster of eight initiations on July 7 — Deutsche Bank at $255, Bernstein at $239, Cantor Fitzgerald at $246, Macquarie and William Blair both Outperform — that produced the stock's worst single-session performance of the week. The consensus mean now reads $244.50, implying roughly 80% upside from current prices. Every coverage initiation has carried a Buy-equivalent rating. The Raymond James $800 target remains a statistical outlier and distorts any simple averaging; stripping it out, the firm-level cluster sits between $217 and $255. The bull case centres on SpaceX's position across launch services, Starlink, and government contracts. The bear case is expressed not in analyst notes but in the borrow market — 167 million shares short, availability near the floor, and a stock that has rejected every bullish catalyst in succession.
Elon Musk holds 46% of shares outstanding. The next largest institutional addition of note is FMR (Fidelity), which added 28 million shares in the period to June 30, bringing its total to 138 million. BlackRock initiated a position of 10.5 million shares in the same period. Those are meaningful institutional endorsements — but they predate the sharp July short build, and it is unclear whether those flows have continued into the current drawdown.
August 6 earnings are the next hard stop. Between now and then, the question is whether the record short position begins to move — in either direction — as the price gap between the $136 stock and the $244 consensus mean either narrows on fundamental news or widens further on continued selling pressure.
See the live data behind this article on ORTEX.
Open SPCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
